The global animal vaccine market size valued USD 8,700 million in 2018 and anticipated to grow at the CAGR of 6.5% during the forecast period (2018-2023). Vaccination have a significant part in protecting animal and public health. Vaccination of animals ensures the prevention of possibly hazardous infectious diseases and sustain the productivity of animal protein production. The growing trend of adoption of pets is triggering the growth of the market by creating high demands for animal vaccines. Pets are vaccinated against infectious diseases such as rabies, distemper, and hepatitis. According to the European Pet Food Industry Federation, 80 million households owned pet animals in the European Union in 2016 of which 18% were pet dogs and 26% pet cats. France, Italy, the UK., Ukraine and Germany were in the list of top ten countries with the largest cat population, while France and Romania had the largest dog population in Europe. Leptospirosis is one of the key bacterial diseases which occur in 60% of UK dairy herds. The most common preventive measure for this disease is vaccination. In US, an estimated 78 million dogs and 85.8 million cats are owned accounting for 44% households owing dogs, and 35% owing cat, according to American Pet Products Association 2015-2016.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/animal-vaccine-market

The factors contributing to the growth of the market include the increasing incidences of zoonotic diseases, factory farming method leading to many diseases among animals, and diseases due to climate change. The introduction of new animal vaccines by the major key companies such as Zoetis, and Boehringer Ingelheim for animal health is further augmenting the growth of the market. Initiatives taken by several governments such as the European government and animal wellness programs led by various animal welfare organisations is driving the market growth. Animal Association of Avian Pathologists, American Feed Industry Association, and National Turkey Federation are some of the animal welfare organizations actively working for animal health.

Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/animal-vaccine-market

However, strict and complex regulatory policies delay the reach of vaccines in the market. The storage of vaccines adds to maintenance costs as proper temperature conditions are needed for its storage. These are hindering the growth of the market. Increasing awareness regarding animal welfare, government initiatives to support R&D will have positive growth outlook for the market in the future.

The animal vaccine market is segmented on the basis of type and technology. On the basis of type of vaccines, the market is bifurcated into porcine vaccines, poultry vaccines, livestock vaccines, aquaculture vaccines, companion animal vaccines and other animal vaccines. On the basis of technology, the market is segmented into live whole virus vaccines, killed whole virus vaccines, subunit vaccines, recombinant virus vaccines, anti-idiotype antibodies, DNA vaccines, gene deleted marker vaccines, chimeric vaccines. The live whole virus vaccines segment is expected to account for one of the largest share of the market in 2017 due to the ease of administration and long-term immunity offered by the live attenuated vaccine technologies.

The global animal vaccine market is analysed on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America is expected to be the largest market for animal vaccines market, followed by Europe. High adoption rate of pets, high meat consumption and their mandatory vaccination are the major factors for the US market share. APAC region is estimated to be the fastest growing market during the forecast period – due to its increasing consumption and trade of meat. China’s increasing demand for meat is making it one of the lucrative markets for animal healthcare products for food animals. China consumes around 28% of the world’s meat according to the Organisation for Economic Co-operation and Development and The Food and Agriculture Organization of the United Nations FAO in 2014 accounting for 86,000 tonnes of meat. China consumed about 25% of the total meat produced globally in 2012 with the consumption of 71.2 million tons according to United States Department of Agriculture (USDA). Additionally, it is the largest swine meat consumer globally as well.

The companies contributing to the growth of global animal vaccine market are Zoetis, Elanco(Eli-Lilly), Merck & Co. Inc., Boehringer Ingelheim Bayer, Ceva Animal Health, Valneva Technologies, and Virbac S.A and so on. Majority of key players are acquiring or entering into strategic alliance with other key players from the market to gain a competitive edge over others and enhance their presence. Recently in January 2017, Valneva signed a research license agreement with Merck Animal Health which grants Merck the rights to research new vaccine candidates using Valneva’s EB66 technology. In January 2017, Boehringer Ingelheim completed the acquisition of Merial, animal healthcare division of Sanofi, for the expansion of its business.

MARKET SEGMENTATION

GLOBAL ANIMAL VACCINE MARKET BY TYPE
PORCINE VACCINES
POULTRY VACCINES
LIVESTOCK VACCINES
AQUACULTURE VACCINES
COMPANION ANIMAL VACCINES
OTHER ANIMAL VACCINES
GLOBAL ANIMAL VACCINE MARKET BY TECHNOLOGY
LIVE WHOLE VIRUS VACCINES
KILLED WHOLE VIRUS VACCINES
SUBUNIT VACCINES
RECOMBINANT VIRUS VACCINES
ANTI-IDIOTYPE ANTIBODIES
DNA VACCINES
GENE DELETED MARKER VACCINES
CHIMERIC VACCINES
COMPETITIVE LANDSCAPE

KEY COMPANY ANALYSIS
KEY STRATEGY ANALYSIS
REGIONAL ANALYSIS

NORTH AMERICA
UNITED STATES
CANADA
EUROPE
UNITED KINGDOM
FRANCE
GERMANY
ITALY
SPAIN
REST OF EUROPE
ASIA PACIFIC
INDIA
CHINA
JAPAN
KOREA
ROAPAC
REST OF THE WORLD
COMPANY PROFILES

BAYER ANIMAL HEALTH
BIOGENESIS BAGO A.S
MERIAL (BOEHRINGER INGELHEIM)
CEVA ANIMAL HEALTH LLC
ELANCO (A DIVISION OF ELI-LILLY)
HESTER BIOSCIENCES LIMITED
HIPRA
HYGIEIA BIOLOGICAL LABORATORIES
INDOVAX PVT. LTD.
JINYU BIO-TECHNOLOGY CO. LTD.
MSD ANIMAL HEALTH
NEOGEN CORPORATION
NISSEIKEN CO. LTD.
TEXAS VET LAB, INC.
UNITED VACCINES, INC.
VIRBAC S.A
VENTOQUINOL S.A
ZOETIS INC.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/animal-vaccine-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari

Email: [email protected]
Contact no: +91 780-304-0404